Patent · US Active

Diblock copolymers and polynucleotide complexes thereof for delivery into cells

US9476063B2 · kind B2 · utility

8Cited by
21References
32Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 13, 2009
Grant dateOct 25, 2016
Priority date
Expiry dateOct 13, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/32
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are copolymers, and methods of making and utilizing such copolymers. Such copolymers have at least two blocks: a first block that has at least one unit that is hydrophilic at physiologic pH, and a second block that has hydrophobic groups. This second block further has at least one unit with a group that is anionic at about physiologic pH. The described copolymers are disruptive of a cellular membrane, including an extracellular membrane, an intracellular membrane, a vesicle, an organelle, an endosome, a liposome, or a red blood cell. Preferably, in certain instances, the copolymer disrupts the membrane and enters the intracellular environment. In specific examples, the copolymer is endosomolytic.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.